Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.
Beximco Pharmaceuticals Limited has successfully appealed to the Bangladesh Supreme Court, leading to the immediate lifting of its trading suspension on AIM. The Court’s decision exempts Beximco Pharma from a previous order to appoint a receiver for the group. The High Court has been directed to resolve a related pending case within two weeks.
For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Alphabet’s Waymo Expands Robotaxi Rides in Los Angeles to All Passengers
- Pfizer Considers Selling Hospital Unit to Free Up Cash and Reduce Debt
- Trump’s Win Is Good News for Alphabet Stock, Says Top Investor
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
